4D Molecular Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() AKRO
Akero Therapeutics, Inc. |
$37.45 | $2.98 B | -9.99 | 63 |
![]() BCEL
Atreca, Inc. |
$0.09 | $3.57 M | -0.04 | 90 |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$1.37 | $77.34 M | -1.07 | 24 |
![]() BMEA
Biomea Fusion, Inc. |
$1.59 | $57.44 M | -0.41 | 106 |
![]() CCCC
C4 Therapeutics, Inc. |
$1.11 | $78.44 M | -0.73 | 110 |
![]() CGEM
Cullinan Oncology, Inc. |
$7.61 | $445.28 M | -2.74 | 111 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$13.03 | $1.37 B | -8.99 | 110 |
![]() FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 |
![]() GOSS
Gossamer Bio, Inc. |
$0.83 | $188.59 M | -3.32 | 144 |
![]() IPSC
Century Therapeutics, Inc. |
$0.51 | $43.83 M | -0.32 | 140 |
![]() KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.62 | 10 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.09 | $5.93 M | -0.06 | 30 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.52 | $877.13 M | -3.69 | 51 |
![]() NVCT
Nuvectis Pharma, Inc. |
$8.88 | $207.72 M | -8 | 13 |
![]() PASG
Passage Bio, Inc. |
$0.33 | $20.45 M | -0.31 | 60 |
![]() REPL
Replimune Group, Inc. |
$7.64 | $588.39 M | -2.49 | 331 |
![]() RVMD
Revolution Medicines, Inc. |
$36.20 | $6.73 B | -10.11 | 534 |
![]() STOK
Stoke Therapeutics, Inc. |
$7.58 | $409.91 M | -4.59 | 128 |
![]() TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 |